Rivomycin
Brand names,
Rivomycin
Analogs
Rivomycin
Brand Names Mixture
Rivomycin
Chemical_Formula
C11H12Cl2N2O5
Rivomycin
RX_link
http://www.rxlist.com/cgi/generic3/chloramphenicol.htm
Rivomycin
fda sheet
Rivomycin
msds (material safety sheet)
Rivomycin
Synthesis Reference
No information avaliable
Rivomycin
Molecular Weight
323.129 g/mol
Rivomycin
Melting Point
150.5 oC
Rivomycin
H2O Solubility
2500 mg/L (at 25 °C)
Rivomycin
State
Solid
Rivomycin
LogP
1.476
Rivomycin
Dosage Forms
Capsule; Drops; Liquid; Ointment; Powder; Solution; Suspension; Tablet
Rivomycin
Indication
Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.
Rivomycin
Pharmacology
Chloramphenicol is a broad-spectrum antibiotic that was derived from the bacterium Streptomyces venezuelae and is now produced synthetically. Chloramphenicol is effective against a wide variety of microorganisms, but due to serious side-effects (e.g., damage to the bone marrow, including aplastic anemia) in humans, it is usually reserved for the treatment of serious and life-threatening infections (e.g., typhoid fever). Chloramphenicol is bacteriostatic but may be bactericidal in high concentrations or when used against highly susceptible organisms. Chloramphenicol stops bacterial growth by binding to the bacterial ribosome (blocking peptidyl transferase) and inhibiting protein synthesis.
Rivomycin
Absorption
Rapidly and completely absorbed from gastrointestinal tract following oral administration (bioavailability 80%). Well absorbed following intramuscular administration (bioavailability 70%). Intraocular and some systemic absorption also occurs after topical application to the eye.
Rivomycin
side effects and Toxicity
Oral, mouse: LD50 = 1500 mg/kg; Oral, rat: LD50 = 2500 mg/kg. Toxic reactions including fatalities have occurred in the premature and newborn; the signs and symptoms associated with these reactions have been referred to as the gray syndrome. Symptoms include (in order of appearance) abdominal distension with or without emesis, progressive pallid cyanosis, vasomotor collapse frequently accompanied by irregular respiration, and death within a few hours of onset of these symptoms.
Rivomycin
Patient Information
No information avaliable
Rivomycin
Organisms Affected
Enteric bacteria and other eubacteria